{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0009823/OMIM:259900","label":"Hyperoxaluria, primary, type I","mondoId":"MONDO:0009823","onsetQualifier":null,"recordKeys":["054900db6436cd10c935486ef3df88287fa0a978d386bfd20c8ae71ca1ab174d","07af6f00904a261712fcde80c2103eeee0baf8f8aa4ef501201429a4cb810b09","0ee4816ffc07ff368cc4c246b15ed1584a775f2c60fa8d8616bfac3f25e47569","1e62f7397bd9dcc044d8a807abae482d7bc68101763a7e47d462c3c039cacd21","39ef4fc0468c290acf363b10bd0fc8cd71bebac286c1038c7292cfa070eb8773","41c4033310c5c5b17009973bf0c2c4e536ec28b397b4eb4b159905df88fdf256","5482e2946aa410ffae8b12c6416dacab0aa1f65200d183a3f39f3b96d75ea285","5cd6562400518022108d9070cee1d4c9958e4d5518a348ce0bc66dabe463b198","67a866e72944b963e62a2fc0717197009c6508344d1505e707a500738e029e07","80ba6148cba3ed9c0a39a5e529a0b497bd90cc65fd32c9b9929754e0e0c4047c","94097ce1b89b89019ab09ec423819e9da27ea08cfcf56476eb78c56f8e3e38de","9a32a06948e0f9158aa6b30c4d22841b15c483eab6bcb8956fb38e2333995349","9c7743e0ad239784bf7dff7f5579d29ecb8329ff587808268aac6ad3cd8c94fe","ab79f110d18c2e722e1f2a6f1776c220bc1dd5f807ecdb9bbdb67a40cd1f3bc8","c94d7200dd54fcc293965121dfb1613de325a39b40797dfc2be8541360b9e88d","ccf55bc357db621ab9e761d8f5aa511ac18a44d63ed0c8661228ef9f218a01bf","cfaa1e7f3da8f46d5155ab7884acde746c1fb3fb341f4997241244f7d35d3ec2","d3c909b0dbe58e880bed7f6808297de19ade9c70b22a383faa787e55cf853696","d3db3b8e946bb368b403c3e1a655a1589befd49c1c620212767e6ddeacce38c9","d3ee045c75afcee13dd1b0676171034e8dd29cb5dd804e1f05813049e142b9a9","d7f11fb7a8e737c6589b066b5ab7d8e5735fbedef3768932b18c183a287f82a9","da2e0544db03cc3f4d4b0eebab26303d2e068ce298f1270247b25e7f36e14651","e25e722c40fefe8c70b05725c64f70acceb0508489c3f0a9c4c9bb62b639a317","e509a7adb7216565fac334d760d939876a400933c4f29d91f6a137d1161551f3","e837a9340b2583e869505a0dbd8725eed04c0d8bf2b26defe0df66a65af39893","ea952d01b08fcf2bf9bac8e9b40da2692ec425b37cf72531715daaa6f8e75568","edf6f03dd51a8a850b0a92b88a37885ef0f132713d1000b7a9c5742f8ca8310e","eeadf09b54ef2493d1140a56b660ceb168f10d0cc7ce746f1a47a7123be977cf"],"recordQualifiers":{},"scopeLabel":"OMIM:259900","sourceIds":["OMIM:259900"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009824/OMIM:260000","label":"Hyperoxaluria, primary, type II","mondoId":"MONDO:0009824","onsetQualifier":null,"recordKeys":["14c7d60341fcd3b237dd42fa8acff7fa2c25d8765a3c86d55ba8ed3956cdc627","35329779388df02c62fd93ccde6d8cd366eb9189140e42030478210ad0ba7489","7e1f3a8efbfeaef9db68c9f9570a5c818e3738766a4a6963b808d10c745ad956","8588c6abdc6d9a5d1503f324fe639e12c50dfe098711ed398e1972a9368d0f18","a212c0feaaecf3a1631c09141cf7f4a79de329c18c2e4039ee89c6b29a014a64","ca3a44c692a4308ea72dd37dcbd5f3121832b3b2f315d0eed8a0d7fff603ce12","cc76bce07e8f7d102811d4ff4980740780f9ca445583276eb0c88dca7adeb092","dce52c7418f0f53e879fd7851505acc9457ab1135922b8e5be43eb23724d137c","ee06602c7310898f726a6afd383c586d61354f4ae79c6e972c191d1157c2ba1c","faebe6f207d9a2d24e38efc9b1e8d67c748bc487ee4de64f29335d9230007a8c"],"recordQualifiers":{},"scopeLabel":"OMIM:260000","sourceIds":["OMIM:260000"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0013327/OMIM:613616","label":"Hyperoxaluria, primary, type III","mondoId":"MONDO:0013327","onsetQualifier":null,"recordKeys":["0f25a88c1d697f50b45c086ceace8d6bd3c882beaa2a393a465922645fe53702","3e4873c2077d114876b6aa85fbfc7abaa8762153d6aeb0acb67375520936591d","48b5cb375ef1b75adf1c3d4c757d785338c5d7a84ab4a7e75d1a0c3f9cd2c03b"],"recordQualifiers":{},"scopeLabel":"OMIM:613616","sourceIds":["OMIM:613616"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0002474/ORPHA:416","label":"Primary hyperoxaluria","mondoId":"MONDO:0002474","onsetQualifier":null,"recordKeys":["00d6faad0385e5811d158b78442a89e3d9ebd085c8ab9ca356d0b766ef10dc08","0bd74ac5bf2f2f3322f54ffddd02bb598dfa66fa3b779861f365d6eeab6ac07d","0ccba793f32fbee8f16a4d27ed777efe363f8d3fdbdc300e0ecc60ff5e3d596a","0ddc76f79a2089507eb89b84e65bba6572de31abb249996015da78da903b9157","11f17a15917923bb43662a6b13a978a86eb9d3143003b7096d83a465e575dc0d","1a8e9c455ddb4ed246225e6478f76fea326451ab6a815d478b51966f69343456","2945842ab0d7035e4577a37c48587d08f809e4d67f305acf0ae866c649e7a5d5","33e951d1487a5e9c08a58bb4fc288fffd58b3b8a8883ee8e5342b03dfc00596c","354903d80685a9507098f17d00bb7f3b9d929580f54e41c43dc5dbb6256248bd","430e9bbe964c822bc72536d5ab6a252dbd5a3a94c074f76baab374de6e5ea98e","65f5fb8316c587609264567adbfc6591af9b10a487587c8853189c3e70fc925c","6f8912bb36f19d70d45812077d68152f19d8b6efd3452d0c371b1f06532d002a","72713ddb772d009c765f58b7e6ca1288c9ca7db2b7176ec94996abe962c4a86d","80f8567be53a096fd17f2005bfa0070c633901cc9e1d9949993419a311fd6c27","83b6c91104c79d11b266e00c16310a68c23ba543c19420b2d1724caada3d2b56","865c82b4660b5e36387c3097eadb8b71dae65042205a150e6412e7a563366bdf","8791e6ac5a3ce4254cf365016052ef911fd026b340c3f0c53d5a052c3052756f","8fc657743064fd3339b1e506fb6f8e1e76169940aac431861d1c47ec6a2fe01b","9390179b8c28aba4bf74bbb828663d87bf52bb59e48df38eaa61317ca4b0788c","9afdfbc419809e62951dc0f948002be134a9d47b2db7ea01dee0ad65ed8de2bc","a6386efe85210c7761ecbd91e402462c04c6d012121a0097b83f1a656844002f","be06146b0f2194ebd21188c30e9dc2bf0f6974b18007f7c8e41afd67b9ccd2da","d0f490ca7417820a7d9d621bb558498840774ca87530ae7018c11845054afff2","d76ad730611a341537d419cfac061dc6c33e9d6a4cc8398d36eb3d0eea645bdf","db1d5340445c30f9b06efcac7b4bc87d4765ff44d48b6786337c356b20031ded","e0435ae1716d719f80402c63fce20643c70f2ef0b68bc7330b3dd13eae242f24","e0b9dc25319b39131c86cd0157b5e2e78976f9a82545f8ec392c429b3e6b7099","e3f6a0d880e79c7d9e1a84136ba3a83c83950fafbdbcdcd9ef4d309a8914eccd","e69203a784c83269e81aa308ffaf9b25ddea12b070052b490b2fd356f9ec0193","e6c1db8aa8c569b55dcf153dd45ebb1bc64ee6b81c06b18dadf865a6922fec0b","f131b93ed07c3c78b4f9a5c50eb61fd7bf3c97b69719f284e64aa1a304a91bb1","f164bf6dfe3dd4e61a77ed999e07564d1ce79e328d599bf09c71828a9ce621d3","f5bb94b3a04f6a53ce7d3e656c0f278a340823e98da3e01feebef152ed0ed96a"],"recordQualifiers":{},"scopeLabel":"ORPHA:416","sourceIds":["ORPHA:416"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009823/ORPHA:93598","label":"Primary hyperoxaluria type 1","mondoId":"MONDO:0009823","onsetQualifier":null,"recordKeys":["23aba4817b7b2a1bb073c7515da2e09c6d04778c9d635c4f492a596528d2215d","3a0f00099324a590e33d3dbdcbc21e73bc2479dec910b90db010731ffbcbfd45","4d4044a3ba47aba89d64f8d3cd87f6f98cc4b4cd97a4af8740124c19aa9ca135","4d6cea65fdb43ea4570103186e5ead118c565d81a5e032d9379d7137064b2171","4f8a154ee605a97085b3d150d3a7a814af1321173fce70e69af64d6c524e9d64","5936aa488f9fed457e56aa3004875c972fe721c756e98bb8895a064a0dd53c46","5c9f7257faac96eaffe0351e9461f3698fa95df9dc2357085735e6c232f7a304","678188c53461305c1af87c432fcd12fb98562207f784f4c4c8ecbcbc59a930c8","75628f5bc7bcae99e72a882046e6de45aaf98934c3cb02459b616a3334bf06fc","77a4e41c312866a5f6645517a9024ae0e5969efe8176643260235d549cb024f5","8a3fb56b34ed61c50033d41f4358d2ff13df9815d4187aa8bbf82f5f0d48dae5","938f83c8d28a370baac39bae1bc815c7436f2eebad2bf1bca10a828939509125","a37d1e2e85f4e0d9f255e13c6cc888525baea20b939da68635f114b4bfb520a3","bcf4ff6d9d6189ae5af4d4f02be527d876f9c198d657d4734f94829f139a32f6","d78fe3b713672c7971b030801e5e3072bbfa180f4915b613f91c3de773f5b477","daa42829d012fd35ba4d3c7bbaec04dc283c9abc21addac74d19e72b1a60bb43","e46f6286d15916ab71916c327bd692f08b32d33f4a8998de334ee5d1cf47019d","f9c1ab898489b8d994eb1652606496e6724b26efd850e1056a0243483216b2e5","fac1aa3ad7b4a11d6fa545c2cb7a9d19b0aed29795edcc9c27d93618f313b746"],"recordQualifiers":{},"scopeLabel":"ORPHA:93598","sourceIds":["ORPHA:93598"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009824/ORPHA:93599","label":"Primary hyperoxaluria type 2","mondoId":"MONDO:0009824","onsetQualifier":null,"recordKeys":["24b1b9adcfec701633369c53c87cc095c45dcca4b584d1d6b988fa57e6f7a28f","281cd4371b404c065e02d838fd8c1cdbfe233881569d245f60e16e96c4c87db5","36e502131701ac03c697e7ea967427c94fcc85cdf437b2483078d234b40a7659","4dc1799ddaed70cf07affbd79d275f64371c6e5a725da98eed79e09530f229d6","691ef45684b11279cba06c63328ea169bfb7d849037b72c367069c4794ac7cf6","ec70aa00ffb6d048b043cc0e47169d079850287044b0a8dfd7a96b9ee05f3357"],"recordQualifiers":{},"scopeLabel":"ORPHA:93599","sourceIds":["ORPHA:93599"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0013327/ORPHA:93600","label":"Primary hyperoxaluria type 3","mondoId":"MONDO:0013327","onsetQualifier":null,"recordKeys":["066c50540b005e9739a99b609ff90a180bc95daa3353dbe53b3b59223d6d4237","119dcc617eda893e8a1f4a1db1381b3ff9772f802bd2821024c1b46d2deb0ade","4a9a99e73a91d403ee1de43559ba68938fd2f76f388972dcb2356d11e5a330b2","5d743d276515e7e4ac6df5279ef23f664c01d0b55dfcaee6c5bd1ab1a4982a87","72950b28fa38a08c492ab96786225a9c423ecb2111e63a618c83ba3a3ea66158","8e9392c58c4cd81c61615db40939ff4d07ac1f06422bf8cb2be3c7aa0dfe1969","a29d71870070c32385639f88160fa661334a3b13c4d917de2da69670e99d4e05","ba58df543a473b536b22fbb325846f1edba5b9fa7ba47f1a102f17d80c77f828","eae073230a6df989e8b4aae7d019ed1d699d7bbd95d185e46402a318f89e84e5"],"recordQualifiers":{},"scopeLabel":"ORPHA:93600","sourceIds":["ORPHA:93600"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0009823/OMIM:259900","MONDO:0009824/OMIM:260000","MONDO:0013327/OMIM:613616","MONDO:0002474/ORPHA:416"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"

Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.

"},"coverage":{"countRecords":13,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":108,"sourceGroups":{"omim":21,"orphanet":67,"published":20}},"features":[{"hpoId":"HP:0012100","label":"Abnormal circulating creatinine concentration","primary":false},{"hpoId":"HP:0011021","label":"Abnormal circulating enzyme concentration","primary":false},{"hpoId":"HP:0006479","label":"Abnormal dental pulp morphology","primary":false},{"hpoId":"HP:0012211","label":"Abnormal renal physiology","primary":false},{"hpoId":"HP:0001939","label":"Abnormality of metabolism/homeostasis","primary":false},{"hpoId":"HP:0000164","label":"Abnormality of the dentition","primary":false},{"hpoId":"HP:0000924","label":"Abnormality of the skeletal system","primary":false},{"hpoId":"HP:0011280","label":"Abnormality of urine calcium concentration","primary":false},{"hpoId":"HP:0003110","label":"Abnormality of urine homeostasis","primary":false},{"hpoId":"HP:0012072","label":"Aciduria","primary":false},{"hpoId":"HP:0001063","label":"Acrocyanosis","primary":false},{"hpoId":"HP:0001903","label":"Anemia","primary":false},{"hpoId":"HP:0025324","label":"Arterial occlusion","primary":false},{"hpoId":"HP:0002621","label":"Atherosclerosis","primary":false},{"hpoId":"HP:0001678","label":"Atrioventricular block","primary":false},{"hpoId":"HP:0002653","label":"Bone pain","primary":false},{"hpoId":"HP:0003761","label":"Calcinosis","primary":false},{"hpoId":"HP:0025520","label":"Calcinosis cutis","primary":false},{"hpoId":"HP:0008672","label":"Calcium oxalate nephrolithiasis","primary":false},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":false},{"hpoId":"HP:0011506","label":"Choroidal neovascularization","primary":false},{"hpoId":"HP:0012622","label":"Chronic kidney disease","primary":false},{"hpoId":"HP:0000965","label":"Cutis marmorata","primary":false},{"hpoId":"HP:0012213","label":"Decreased glomerular filtration rate","primary":false},{"hpoId":"HP:0001944","label":"Dehydration","primary":false},{"hpoId":"HP:0100518","label":"Dysuria","primary":false},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":false},{"hpoId":"HP:6000431","label":"Elevated urinary glycolic acid level","primary":false},{"hpoId":"HP:6000702","label":"Elevated urinary glyoxylic acid level","primary":false},{"hpoId":"HP:6000670","label":"Elevated urinary L-glycerate level","primary":false},{"hpoId":"HP:0031981","label":"Elevated urine glycolate","primary":false},{"hpoId":"HP:0000805","label":"Enuresis","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0005789","label":"Generalized osteosclerosis","primary":false},{"hpoId":"HP:0012722","label":"Heart block","primary":false},{"hpoId":"HP:0000790","label":"Hematuria","primary":false},{"hpoId":"HP:0002150","label":"Hypercalciuria","primary":false},{"hpoId":"HP:0003159","label":"Hyperoxaluria","primary":false},{"hpoId":"HP:0011001","label":"Increased bone mineral density","primary":false},{"hpoId":"HP:6001009","label":"Increased urine 4-hydroxy-2-oxoglutarate level","primary":false},{"hpoId":"HP:0004417","label":"Intermittent claudication","primary":false},{"hpoId":"HP:0000787","label":"Kidney stone","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000543","label":"Optic disc pallor","primary":false},{"hpoId":"HP:0001138","label":"Optic neuropathy","primary":false},{"hpoId":"HP:0012531","label":"Pain","primary":false},{"hpoId":"HP:0002756","label":"Pathologic fracture","primary":false},{"hpoId":"HP:0004950","label":"Peripheral arterial stenosis","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0100515","label":"Pollakisuria","primary":false},{"hpoId":"HP:0030880","label":"Raynaud phenomenon","primary":false},{"hpoId":"HP:0002757","label":"Recurrent fractures","primary":false},{"hpoId":"HP:0000010","label":"Recurrent urinary tract infections","primary":false},{"hpoId":"HP:0035005","label":"Reduced hepatic alanine-glyoxylate aminotransferase activity","primary":false},{"hpoId":"HP:6000638","label":"Reduced hepatic glyoxylate reductase activity","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0030507","label":"Retinal crystals","primary":false},{"hpoId":"HP:0000488","label":"Retinopathy","primary":false},{"hpoId":"HP:0011072","label":"Rootless teeth","primary":false},{"hpoId":"HP:0003774","label":"Stage 5 chronic kidney disease","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false},{"hpoId":"HP:0006000","label":"Ureteral obstruction","primary":false}],"ledeHtml":"Primary hyperoxaluria is a rare condition characterized by recurrent kidney and bladder stones. The condition often results in end stage renal disease (ESRD), which is a life-threatening condition that prevents the kidneys from filtering fluids and waste products from the body effectively.","mondoId":"MONDO:0002474","records":[{"frequencyKind":"range","key":"00d6faad0385e5811d158b78442a89e3d9ebd085c8ab9ca356d0b766ef10dc08","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"054900db6436cd10c935486ef3df88287fa0a978d386bfd20c8ae71ca1ab174d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"066c50540b005e9739a99b609ff90a180bc95daa3353dbe53b3b59223d6d4237","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003110","is_excluded":false,"label":"Abnormality of urine homeostasis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"07af6f00904a261712fcde80c2103eeee0baf8f8aa4ef501201429a4cb810b09","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0035005","is_excluded":false,"label":"Reduced hepatic alanine-glyoxylate aminotransferase activity","onset_id":null,"reference":"PMID:2880111","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0bd74ac5bf2f2f3322f54ffddd02bb598dfa66fa3b779861f365d6eeab6ac07d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005789","is_excluded":false,"label":"Generalized osteosclerosis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ccba793f32fbee8f16a4d27ed777efe363f8d3fdbdc300e0ecc60ff5e3d596a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002150","is_excluded":false,"label":"Hypercalciuria","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ddc76f79a2089507eb89b84e65bba6572de31abb249996015da78da903b9157","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0ee4816ffc07ff368cc4c246b15ed1584a775f2c60fa8d8616bfac3f25e47569","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0f25a88c1d697f50b45c086ceace8d6bd3c882beaa2a393a465922645fe53702","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"PMID:20797690","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"119dcc617eda893e8a1f4a1db1381b3ff9772f802bd2821024c1b46d2deb0ade","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"11f17a15917923bb43662a6b13a978a86eb9d3143003b7096d83a465e575dc0d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"14c7d60341fcd3b237dd42fa8acff7fa2c25d8765a3c86d55ba8ed3956cdc627","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0011280","is_excluded":true,"label":"Abnormality of urine calcium concentration","onset_id":null,"reference":"PMID:28569194","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1a8e9c455ddb4ed246225e6478f76fea326451ab6a815d478b51966f69343456","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011072","is_excluded":false,"label":"Rootless teeth","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1e62f7397bd9dcc044d8a807abae482d7bc68101763a7e47d462c3c039cacd21","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"23aba4817b7b2a1bb073c7515da2e09c6d04778c9d635c4f492a596528d2215d","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012213","is_excluded":false,"label":"Decreased glomerular filtration rate","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24b1b9adcfec701633369c53c87cc095c45dcca4b584d1d6b988fa57e6f7a28f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006000","is_excluded":false,"label":"Ureteral obstruction","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"281cd4371b404c065e02d838fd8c1cdbfe233881569d245f60e16e96c4c87db5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2945842ab0d7035e4577a37c48587d08f809e4d67f305acf0ae866c649e7a5d5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012072","is_excluded":false,"label":"Aciduria","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"33e951d1487a5e9c08a58bb4fc288fffd58b3b8a8883ee8e5342b03dfc00596c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025324","is_excluded":false,"label":"Arterial occlusion","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"35329779388df02c62fd93ccde6d8cd366eb9189140e42030478210ad0ba7489","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0012100","is_excluded":true,"label":"Abnormal circulating creatinine concentration","onset_id":null,"reference":"PMID:28569194","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"354903d80685a9507098f17d00bb7f3b9d929580f54e41c43dc5dbb6256248bd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012722","is_excluded":false,"label":"Heart block","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36e502131701ac03c697e7ea967427c94fcc85cdf437b2483078d234b40a7659","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"39ef4fc0468c290acf363b10bd0fc8cd71bebac286c1038c7292cfa070eb8773","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004417","is_excluded":false,"label":"Intermittent claudication","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3a0f00099324a590e33d3dbdcbc21e73bc2479dec910b90db010731ffbcbfd45","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000164","is_excluded":false,"label":"Abnormality of the dentition","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3e4873c2077d114876b6aa85fbfc7abaa8762153d6aeb0acb67375520936591d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6001009","is_excluded":false,"label":"Increased urine 4-hydroxy-2-oxoglutarate level","onset_id":null,"reference":"PMID:26401545","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"41c4033310c5c5b17009973bf0c2c4e536ec28b397b4eb4b159905df88fdf256","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002756","is_excluded":false,"label":"Pathologic fracture","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"430e9bbe964c822bc72536d5ab6a252dbd5a3a94c074f76baab374de6e5ea98e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"48b5cb375ef1b75adf1c3d4c757d785338c5d7a84ab4a7e75d1a0c3f9cd2c03b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"PMID:20797690","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4a9a99e73a91d403ee1de43559ba68938fd2f76f388972dcb2356d11e5a330b2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012211","is_excluded":false,"label":"Abnormal renal physiology","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d4044a3ba47aba89d64f8d3cd87f6f98cc4b4cd97a4af8740124c19aa9ca135","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d6cea65fdb43ea4570103186e5ead118c565d81a5e032d9379d7137064b2171","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4dc1799ddaed70cf07affbd79d275f64371c6e5a725da98eed79e09530f229d6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4f8a154ee605a97085b3d150d3a7a814af1321173fce70e69af64d6c524e9d64","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003761","is_excluded":false,"label":"Calcinosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5482e2946aa410ffae8b12c6416dacab0aa1f65200d183a3f39f3b96d75ea285","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5936aa488f9fed457e56aa3004875c972fe721c756e98bb8895a064a0dd53c46","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c9f7257faac96eaffe0351e9461f3698fa95df9dc2357085735e6c232f7a304","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100518","is_excluded":false,"label":"Dysuria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5cd6562400518022108d9070cee1d4c9958e4d5518a348ce0bc66dabe463b198","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001138","is_excluded":false,"label":"Optic neuropathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5d743d276515e7e4ac6df5279ef23f664c01d0b55dfcaee6c5bd1ab1a4982a87","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100515","is_excluded":false,"label":"Pollakisuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"65f5fb8316c587609264567adbfc6591af9b10a487587c8853189c3e70fc925c","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001063","is_excluded":false,"label":"Acrocyanosis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"678188c53461305c1af87c432fcd12fb98562207f784f4c4c8ecbcbc59a930c8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011021","is_excluded":false,"label":"Abnormal circulating enzyme concentration","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"67a866e72944b963e62a2fc0717197009c6508344d1505e707a500738e029e07","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0030507","is_excluded":false,"label":"Retinal crystals","onset_id":null,"reference":"PMID:23666469","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"691ef45684b11279cba06c63328ea169bfb7d849037b72c367069c4794ac7cf6","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000010","is_excluded":false,"label":"Recurrent urinary tract infections","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f8912bb36f19d70d45812077d68152f19d8b6efd3452d0c371b1f06532d002a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72713ddb772d009c765f58b7e6ca1288c9ca7db2b7176ec94996abe962c4a86d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030880","is_excluded":false,"label":"Raynaud phenomenon","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72950b28fa38a08c492ab96786225a9c423ecb2111e63a618c83ba3a3ea66158","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012531","is_excluded":false,"label":"Pain","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"75628f5bc7bcae99e72a882046e6de45aaf98934c3cb02459b616a3334bf06fc","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000010","is_excluded":false,"label":"Recurrent urinary tract infections","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77a4e41c312866a5f6645517a9024ae0e5969efe8176643260235d549cb024f5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000805","is_excluded":false,"label":"Enuresis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7e1f3a8efbfeaef9db68c9f9570a5c818e3738766a4a6963b808d10c745ad956","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"PMID:28569194;PMID:10484776","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"80ba6148cba3ed9c0a39a5e529a0b497bd90cc65fd32c9b9929754e0e0c4047c","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001063","is_excluded":false,"label":"Acrocyanosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"80f8567be53a096fd17f2005bfa0070c633901cc9e1d9949993419a311fd6c27","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"83b6c91104c79d11b266e00c16310a68c23ba543c19420b2d1724caada3d2b56","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8588c6abdc6d9a5d1503f324fe639e12c50dfe098711ed398e1972a9368d0f18","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0001942","is_excluded":true,"label":"Metabolic acidosis","onset_id":null,"reference":"PMID:28569194","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"865c82b4660b5e36387c3097eadb8b71dae65042205a150e6412e7a563366bdf","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8791e6ac5a3ce4254cf365016052ef911fd026b340c3f0c53d5a052c3052756f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8a3fb56b34ed61c50033d41f4358d2ff13df9815d4187aa8bbf82f5f0d48dae5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8e9392c58c4cd81c61615db40939ff4d07ac1f06422bf8cb2be3c7aa0dfe1969","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8fc657743064fd3339b1e506fb6f8e1e76169940aac431861d1c47ec6a2fe01b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002757","is_excluded":false,"label":"Recurrent fractures","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"938f83c8d28a370baac39bae1bc815c7436f2eebad2bf1bca10a828939509125","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9390179b8c28aba4bf74bbb828663d87bf52bb59e48df38eaa61317ca4b0788c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011506","is_excluded":false,"label":"Choroidal neovascularization","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"94097ce1b89b89019ab09ec423819e9da27ea08cfcf56476eb78c56f8e3e38de","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001678","is_excluded":false,"label":"Atrioventricular block","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9a32a06948e0f9158aa6b30c4d22841b15c483eab6bcb8956fb38e2333995349","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9afdfbc419809e62951dc0f948002be134a9d47b2db7ea01dee0ad65ed8de2bc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9c7743e0ad239784bf7dff7f5579d29ecb8329ff587808268aac6ad3cd8c94fe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a212c0feaaecf3a1631c09141cf7f4a79de329c18c2e4039ee89c6b29a014a64","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:10484776","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a29d71870070c32385639f88160fa661334a3b13c4d917de2da69670e99d4e05","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100518","is_excluded":false,"label":"Dysuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a37d1e2e85f4e0d9f255e13c6cc888525baea20b939da68635f114b4bfb520a3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a6386efe85210c7761ecbd91e402462c04c6d012121a0097b83f1a656844002f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012622","is_excluded":false,"label":"Chronic kidney disease","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ab79f110d18c2e722e1f2a6f1776c220bc1dd5f807ecdb9bbdb67a40cd1f3bc8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000965","is_excluded":false,"label":"Cutis marmorata","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ba58df543a473b536b22fbb325846f1edba5b9fa7ba47f1a102f17d80c77f828","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bcf4ff6d9d6189ae5af4d4f02be527d876f9c198d657d4734f94829f139a32f6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"be06146b0f2194ebd21188c30e9dc2bf0f6974b18007f7c8e41afd67b9ccd2da","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000488","is_excluded":false,"label":"Retinopathy","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c94d7200dd54fcc293965121dfb1613de325a39b40797dfc2be8541360b9e88d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000488","is_excluded":false,"label":"Retinopathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"ca3a44c692a4308ea72dd37dcbd5f3121832b3b2f315d0eed8a0d7fff603ce12","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000670","is_excluded":false,"label":"Elevated urinary L-glycerate level","onset_id":null,"reference":"PMID:28569194","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cc76bce07e8f7d102811d4ff4980740780f9ca445583276eb0c88dca7adeb092","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000638","is_excluded":false,"label":"Reduced hepatic glyoxylate reductase activity","onset_id":null,"reference":"PMID:10484776","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ccf55bc357db621ab9e761d8f5aa511ac18a44d63ed0c8661228ef9f218a01bf","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004950","is_excluded":false,"label":"Peripheral arterial stenosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cfaa1e7f3da8f46d5155ab7884acde746c1fb3fb341f4997241244f7d35d3ec2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011001","is_excluded":false,"label":"Increased bone mineral density","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d0f490ca7417820a7d9d621bb558498840774ca87530ae7018c11845054afff2","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000164","is_excluded":false,"label":"Abnormality of the dentition","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d3c909b0dbe58e880bed7f6808297de19ade9c70b22a383faa787e55cf853696","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0025324","is_excluded":false,"label":"Arterial occlusion","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d3db3b8e946bb368b403c3e1a655a1589befd49c1c620212767e6ddeacce38c9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000431","is_excluded":false,"label":"Elevated urinary glycolic acid level","onset_id":null,"reference":"PMID:4701948","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d3ee045c75afcee13dd1b0676171034e8dd29cb5dd804e1f05813049e142b9a9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d76ad730611a341537d419cfac061dc6c33e9d6a4cc8398d36eb3d0eea645bdf","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004417","is_excluded":false,"label":"Intermittent claudication","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d78fe3b713672c7971b030801e5e3072bbfa180f4915b613f91c3de773f5b477","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d7f11fb7a8e737c6589b066b5ab7d8e5735fbedef3768932b18c183a287f82a9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"da2e0544db03cc3f4d4b0eebab26303d2e068ce298f1270247b25e7f36e14651","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0025520","is_excluded":false,"label":"Calcinosis cutis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"daa42829d012fd35ba4d3c7bbaec04dc283c9abc21addac74d19e72b1a60bb43","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"db1d5340445c30f9b06efcac7b4bc87d4765ff44d48b6786337c356b20031ded","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"dce52c7418f0f53e879fd7851505acc9457ab1135922b8e5be43eb23724d137c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"PMID:28569194;PMID:10484776","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e0435ae1716d719f80402c63fce20643c70f2ef0b68bc7330b3dd13eae242f24","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000543","is_excluded":false,"label":"Optic disc pallor","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0b9dc25319b39131c86cd0157b5e2e78976f9a82545f8ec392c429b3e6b7099","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e25e722c40fefe8c70b05725c64f70acceb0508489c3f0a9c4c9bb62b639a317","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0011506","is_excluded":false,"label":"Choroidal neovascularization","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e3f6a0d880e79c7d9e1a84136ba3a83c83950fafbdbcdcd9ef4d309a8914eccd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0025520","is_excluded":false,"label":"Calcinosis cutis","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e46f6286d15916ab71916c327bd692f08b32d33f4a8998de334ee5d1cf47019d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001939","is_excluded":false,"label":"Abnormality of metabolism/homeostasis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e509a7adb7216565fac334d760d939876a400933c4f29d91f6a137d1161551f3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e69203a784c83269e81aa308ffaf9b25ddea12b070052b490b2fd356f9ec0193","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6c1db8aa8c569b55dcf153dd45ebb1bc64ee6b81c06b18dadf865a6922fec0b","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e837a9340b2583e869505a0dbd8725eed04c0d8bf2b26defe0df66a65af39893","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0030880","is_excluded":false,"label":"Raynaud phenomenon","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ea952d01b08fcf2bf9bac8e9b40da2692ec425b37cf72531715daaa6f8e75568","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"eae073230a6df989e8b4aae7d019ed1d699d7bbd95d185e46402a318f89e84e5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ec70aa00ffb6d048b043cc0e47169d079850287044b0a8dfd7a96b9ee05f3357","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93599","disease_name":"Primary hyperoxaluria type 2","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:93599","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"edf6f03dd51a8a850b0a92b88a37885ef0f132713d1000b7a9c5742f8ca8310e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000702","is_excluded":false,"label":"Elevated urinary glyoxylic acid level","onset_id":null,"reference":"PMID:449695","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ee06602c7310898f726a6afd383c586d61354f4ae79c6e972c191d1157c2ba1c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"PMID:10484776","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"eeadf09b54ef2493d1140a56b660ceb168f10d0cc7ce746f1a47a7123be977cf","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f131b93ed07c3c78b4f9a5c50eb61fd7bf3c97b69719f284e64aa1a304a91bb1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031981","is_excluded":false,"label":"Elevated urine glycolate","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f164bf6dfe3dd4e61a77ed999e07564d1ce79e328d599bf09c71828a9ce621d3","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006479","is_excluded":false,"label":"Abnormal dental pulp morphology","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f5bb94b3a04f6a53ce7d3e656c0f278a340823e98da3e01feebef152ed0ed96a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:416","disease_name":"Primary hyperoxaluria","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000965","is_excluded":false,"label":"Cutis marmorata","onset_id":null,"reference":"ORPHA:416","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f9c1ab898489b8d994eb1652606496e6724b26efd850e1056a0243483216b2e5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fac1aa3ad7b4a11d6fa545c2cb7a9d19b0aed29795edcc9c27d93618f313b746","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000924","is_excluded":false,"label":"Abnormality of the skeletal system","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"faebe6f207d9a2d24e38efc9b1e8d67c748bc487ee4de64f29335d9230007a8c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:260000","disease_name":"Hyperoxaluria, primary, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"OMIM:260000","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO cross-references identify native condition entries. Ancestor membership does not transfer phenotype values between groups.","importantHtml":""},"sections":[{"bodyHtml":"

Mutations in the AGXT, GRHPR, and HOGA1 genes cause primary hyperoxaluria types 1, 2, and 3, respectively. These genes provide instructions for making enzymes that are involved in the breakdown and processing of protein building blocks (amino acids) and other compounds. The enzyme produced from the HOGA1 gene is involved in the breakdown of an amino acid, which results in the formation of a compound called glyoxylate. This compound is further broken down by the enzymes produced from the AGXT and GRHPR genes.

Mutations in the AGXT, GRHPR, or HOGA1 gene lead to a decrease in production or activity of the respective proteins, which prevents the normal breakdown of glyoxylate. AGXT and GRHPR gene mutations result in an accumulation of glyoxylate, which is then converted to oxalate for removal from the body as a waste product. HOGA1 gene mutations also result in excess oxalate, although researchers are unsure as to how this occurs. Oxalate that is not excreted from the body combines with calcium to form calcium oxalate deposits, which can damage the kidneys and other organs.

MedlinePlus Genetics: Causes

","key":"forms","title":"What causes Primary hyperoxaluria?"},{"bodyHtml":"

Primary hyperoxaluria results from the overproduction of a substance called oxalate. Oxalate is filtered through the kidneys and excreted as a waste product in urine, leading to abnormally high levels of this substance in urine (hyperoxaluria). During its excretion, oxalate can combine with calcium to form calcium oxalate, a hard compound that is the main component of kidney and bladder stones. Deposits of calcium oxalate can damage the kidneys and other organs and lead to blood in the urine (hematuria), urinary tract infections, kidney damage, ESRD, and injury to other organs. Over time, kidney function decreases such that the kidneys can no longer excrete as much oxalate as they receive. As a result oxalate levels in the blood rise, and the substance gets deposited in tissues throughout the body (systemic oxalosis), particularly in bones and the walls of blood vessels. Oxalosis in bones can cause fractures.

There are three types of primary hyperoxaluria that differ in their severity and genetic cause. In primary hyperoxaluria type 1, kidney stones typically begin to appear anytime from childhood to early adulthood, and ESRD can develop at any age. Primary hyperoxaluria type 2 is similar to type 1, but ESRD develops later in life. In primary hyperoxaluria type 3, affected individuals often develop kidney stones in early childhood, but few cases of this type have been described so additional signs and symptoms of this type are unclear.

Source: MedlinePlus Genetics

","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"primary-hyperoxaluria","sourceDocuments":[{"name":"Primary hyperoxaluria","reviewed":"2015-12","sections":{"causes":{"fetchedAt":"2026-10-20T20:24:23.791702+00:00","label":"Causes","pageSha256":"9f6101b7ece4d166a050121c35cbf72aab19c1b744b9fa1ea0ad088366111df8","sourceUrl":"https://medlineplus.gov/genetics/condition/primary-hyperoxaluria/#causes","status":"available"}},"source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/primary-hyperoxaluria"}],"sourceNote":"MedlinePlus descriptions and Causes; original HPO annotations.","takeawayHtml":"Cause explanations are from MedlinePlus Genetics. Feature values below retain their original sources and patient groups.","title":"Primary hyperoxaluria"},"schemaVersion":1}